Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|12|2|149-160
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.12, Iss.2, 2006-01, pp. : 149-160
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CTLA4-Ig promising in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. :
Access to resources
Recommend
CTLA4-Ig: a novel immunosuppressive agent
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. :
CTLA4-Ig: First report of drug eruption: case report
Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. :
Engineering high avidity CTLA4Ig for therapy of rheumatic diseases
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 9, 2002-09 ,pp. :